Xcout Intel
Caspian Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Caspian Therapeutics, Inc. among biotechnology companies — ranked by similarity to what Caspian Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Caspian Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Caspian Therapeutics, Inc.
Caspian Therapeutics is a biopharmaceutical company developing menin inhibitors, such as its lead candidate KO-7246, as potential treatments for diabetes and other chronic metabolic diseases. The company focuses on a disease-modifying approach designed to restore the body's insulin-producing capacity through the expansion and enhanced function of pancreatic beta cells.
Caspian Therapeutics, Inc. at a glance
Caspian Therapeutics, Inc. is a biotechnology company headquartered in United States. Its most recent funding round, Series A, raised $50M in September 2026. Xcout tracks 3 named people at Caspian Therapeutics, Inc., including Robert H. Spencer (Executive Officer).
Caspian Therapeutics, Inc. leadership
- Robert H. SpencerExecutive Officer
- Spike LoyDirector
- Troy E. WilsonDirector
Caspian Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $50M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Caspian Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Caspian Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company’s first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Biotech
Biomea Fusion, Inc. is a biopharmaceutical firm dedicated to discovering and developing innovative covalent small molecule therapies. These treatments are specifically designed for individuals suffering from genetically defined cancers and various metabolic ailments. The company's primary drug candidate, BMF-219, is a potent and selective covalent inhibitor of menin, engineered for oral administration. Menin plays a crucial role as a transcriptional regulator in the abnormal signaling pathways found across numerous cancer types. Established in 2017, Biomea Fusion's operations are headquartered in Redwood City, California.
Biotech
Endsulin, Inc. is a biotechnology company developing a liver-directed gene therapy for Type 1 Diabetes. Its proprietary technology aims to re-engineer liver cells to restore the body's natural ability to produce and regulate insulin, eliminating the need for artificial insulin delivery methods.
Similar biotechnology company
Metabolic Solutions Development Company is a private biotechnology and drug discovery company founded in 2006. The firm focuses on investigating novel molecular targets and developing therapeutics to treat diabetes, metabolic syndrome, and related conditions.
Similar biotechnology company
Cambrian BioPharma, Inc. is a biotechnology company headquartered in New York, United States, focused on developing therapeutics to extend human healthspan.
Biotech
Aspect Biosystems develops bioengineered cellular medicines and implantable tissue therapeutics using a proprietary bioprinting platform that integrates AI, computational design, and advanced biomaterials. The company serves the biotechnology and pharmaceutical industries by creating treatments to replace, repair, or supplement biological functions for metabolic and endocrine diseases.
Similar biotechnology company
Carmot Therapeutics, Inc. is a biopharmaceutical company headquartered in Berkeley, California, focused on discovering and developing innovative treatments for metabolic diseases and obesity.
Similar biotechnology company
Mosanna Therapeutics is a biopharmaceutical company with offices in Redwood City, California and Basel, Switzerland. The company focuses on developing novel treatments for metabolic and cardiovascular diseases. It launched with $80 million in funding to advance its clinical pipeline.
Similar biotechnology company
Cirius Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Grand Rapids, Michigan, focused on developing innovative therapies for metabolic and liver diseases.
Similar biotechnology company
Paulex Bio Inc. is a biotechnology company headquartered in San Diego, California, focused on transformative treatments for type 1 and type 2 diabetes. Its lead approach targets beta cell regeneration through an oral administration.
Biotech
Akero Therapeutics is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. The company is dedicated to developing transformational therapies for metabolic dysfunction-associated steatohepatitis and other metabolic diseases.
Biotech
Inventisbio is a biopharmaceutical company that focuses on the discovery and development of innovative drugs for major diseases such as tumors, autoimmune diseases, and metabolic disorders. Utilizing an independent research and development platform, the company creates proprietary drug pipelines targeting oncology drivers, kinases, and autoimmune pathways to serve patients globally.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Caspian Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Caspian Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →